Raymond James Financial Services Advisors’s Moleculin Biotech MBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-806
| Closed | -$44K | – | 2814 |
|
|
2020
Q1 | $44K | Buy |
806
+589
| +271% | +$32.2K | ﹤0.01% | 2311 |
|
|
2019
Q4 | $18K | Hold |
217
| – | – | ﹤0.01% | 2785 |
|
|
2019
Q3 | $22K | Hold |
217
| – | – | ﹤0.01% | 2727 |
|
|
2019
Q2 | $24K | Buy |
217
+71
| +49% | +$7.85K | ﹤0.01% | 2759 |
|
|
2019
Q1 | $11K | Buy |
146
+5
| +4% | +$377 | ﹤0.01% | 2742 |
|
|
2018
Q4 | $13K | Hold |
141
| – | – | ﹤0.01% | 2519 |
|
|
2018
Q3 | $20K | Hold |
141
| – | – | ﹤0.01% | 2746 |
|
|
2018
Q2 | $23K | Hold |
141
| – | – | ﹤0.01% | 2699 |
|
|
2018
Q1 | $23K | Buy |
+141
| New | +$23K | ﹤0.01% | 2473 |
|